George Goodwin - 15 Mar 2022 Form 4 Insider Report for Surgery Partners, Inc. (SGRY)

Signature
/s/ Jennifer Baldock, Attorney-in-Fact
Issuer symbol
SGRY
Transactions as of
15 Mar 2022
Net transactions value
-$2,059,479
Form type
4
Filing time
17 Mar 2022, 17:43:23 UTC
Previous filing
15 Mar 2022
Next filing
21 Mar 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SGRY Common Stock Sale $382,773 -7,761 -7.6% $49.32 94,429 15 Mar 2022 Direct F1, F2
transaction SGRY Common Stock Options Exercise $442,860 +33,000 +35% $13.42 127,429 15 Mar 2022 Direct
transaction SGRY Common Stock Sale $939,488 -18,786 -15% $50.01 108,643 15 Mar 2022 Direct F2
transaction SGRY Common Stock Sale $86,343 -1,697 -1.6% $50.88 106,946 16 Mar 2022 Direct F2, F3
transaction SGRY Common Stock Sale $650,875 -12,500 -12% $52.07 94,446 16 Mar 2022 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SGRY Stock Option (Right to Buy) Options Exercise $442,860 -33,000 -22% $13.42 115,500 15 Mar 2022 Common Stock 33,000 $13.42 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares sold to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of restricted stock on March 13, 2022.
F2 The price reported in Column 4 is a weighted average price. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
F3 Shares sold to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of restricted stock on March 15, 2022.